Cite
HARVARD Citation
Belair, C. et al. (n.d.). DGCR8 is essential for tumor progression following PTEN loss in the prostate. EMBO reports. pp. 1219-1232. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Belair, C. et al. (n.d.). DGCR8 is essential for tumor progression following PTEN loss in the prostate. EMBO reports. pp. 1219-1232. [Online].